BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23762353)

  • 1. Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia.
    Borssén M; Palmqvist L; Karrman K; Abrahamsson J; Behrendtz M; Heldrup J; Forestier E; Roos G; Degerman S
    PLoS One; 2013; 8(6):e65373. PubMed ID: 23762353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia.
    Borssén M; Haider Z; Landfors M; Norén-Nyström U; Schmiegelow K; Åsberg AE; Kanerva J; Madsen HO; Marquart H; Heyman M; Hultdin M; Roos G; Forestier E; Degerman S
    Pediatr Blood Cancer; 2016 Jul; 63(7):1185-92. PubMed ID: 26928953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.
    Haider Z; Larsson P; Landfors M; Köhn L; Schmiegelow K; Flaegstad T; Kanerva J; Heyman M; Hultdin M; Degerman S
    Cancer Med; 2019 Jan; 8(1):311-324. PubMed ID: 30575306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
    J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma.
    Haider Z; Landfors M; Golovleva I; Erlanson M; Schmiegelow K; Flægstad T; Kanerva J; Norén-Nyström U; Hultdin M; Degerman S
    Blood Cancer J; 2020 Apr; 10(4):45. PubMed ID: 32345961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia.
    Borssén M; Nordlund J; Haider Z; Landfors M; Larsson P; Kanerva J; Schmiegelow K; Flaegstad T; Jónsson ÓG; Frost BM; Palle J; Forestier E; Heyman M; Hultdin M; Lönnerholm G; Degerman S
    Clin Epigenetics; 2018; 10():31. PubMed ID: 29515676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.
    Fu HY; Wu DS; Zhou HR; Shen JZ
    Hematology; 2014 Sep; 19(6):329-37. PubMed ID: 24164743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.
    Touzart A; Boissel N; Belhocine M; Smith C; Graux C; Latiri M; Lhermitte L; Mathieu EL; Huguet F; Lamant L; Ferrier P; Ifrah N; Macintyre E; Dombret H; Asnafi V; Spicuglia S
    Haematologica; 2020 Jun; 105(6):1575-1581. PubMed ID: 31537687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
    Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
    Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Calasanz MJ; Garate L; San Jose-Eneriz E; Cordeu L; Prosper F; Heiniger A; Torres A
    Clin Cancer Res; 2006 Aug; 12(16):4845-50. PubMed ID: 16914570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma.
    Koh YW; Chun SM; Park YS; Song JS; Lee GK; Khang SK; Jang SJ
    Tumour Biol; 2016 Aug; 37(8):10675-84. PubMed ID: 26867769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
    Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
    J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Spicuglia S
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3835-40. PubMed ID: 24548444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
    Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
    Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.
    Wu LM; Zhang F; Zhou L; Yang Z; Xie HY; Zheng SS
    BMC Cancer; 2010 Aug; 10():399. PubMed ID: 20678188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.
    Chen HY; Zhu BH; Zhang CH; Yang DJ; Peng JJ; Chen JH; Liu FK; He YL
    Cancer Sci; 2012 Jan; 103(1):73-9. PubMed ID: 22017425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.